TMEM108 inhibitors belong to a class of chemical compounds designed to target and modulate the activity of the transmembrane protein 108, abbreviated as TMEM108. TMEM108 is a relatively less characterized protein in the field of molecular and cellular biology, and its precise functions are still being elucidated. It is classified as a transmembrane protein, indicating its localization within cellular membranes, and it contains multiple transmembrane domains. TMEM108's specific roles within the cell remain a subject of ongoing research, and its functions appear to be diverse, potentially contributing to various cellular processes.
The development of TMEM108 inhibitors typically involves a combination of biochemical, biophysical, and structural approaches aimed at identifying or designing molecules that can selectively interact with TMEM108 and modulate its activity. By inhibiting TMEM108, these compounds may be used to explore the consequences of its modulation on cellular functions and processes that are potentially influenced by this protein. Researchers use TMEM108 inhibitors as tools to study the functions and interactions of this protein within the context of cell biology, attempting to uncover its roles in cellular pathways and molecular mechanisms.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Chaetocin | 28097-03-2 | sc-200893 | 200 µg | $120.00 | 5 | |
Inhibits histone methyltransferases, which could result in changes to TMEM108 gene expression. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $100.00 $200.00 | 13 | |
Histone acetyltransferase inhibitor which could alter gene expression including that of TMEM108. |